Clinical Trial: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Multinational, Multicenter, Randomized, Comparative, Open-label, Phase 3 Study to Assess the Immunogenicity and Safety of DTaP-IPV (Diphtheria-tetanus-acellular Pertussi

Brief Summary: The objective of this study is to assess the immunogenicity and safety of the DTaP-IPV combination vaccine compared with those of separate DTaP and IPV vaccines administered to healthy infants at 2, 4, and 6 months of age.